Archive | Press Releases RSS feed for this section

I Have WHAT? An Interview With Patient Advocate Debra Berenson

May 24, 2016

0 Comments

Interview with Debra Berenson, myeloma patient advocate, wife of myeloma expert Dr. James Berenson, and author of the book, I HAVE WHAT?. Debra has collected stories, insights, and tools for and from patients and their families with myeloma and related diseases. The second half of the book  includes information and advice from doctors and other healthcare professionals who treat […]

Continue reading...

KIIS Cares Interview

May 21, 2015

0 Comments

What: Myeloma is a disease in your bone marrow. Inside your bone marrow are the cells that make your blood, your red cells, your white cells, and your platelets. This plays a key role in maintaining the strength of the bone. Why: There have been several recent breakthroughs for the treatment of multiple myeloma patients […]

Continue reading...

Updates on Treatment

December 18, 2014

0 Comments

“How do you know if you are getting the right drugs at the right doses for treating your myeloma?”

Continue reading...

Year End 2014

December 9, 2014

0 Comments

The Institute has been involved in very exciting work this year. We have identified new treatments for myeloma, identified new ways to follow the disease and completed research that has led to a better understanding of the biology of myeloma. First, we have found that a drug named Jakafi, that is used to treat a […]

Continue reading...

Tommy Garceau, IMBCR’s Marathon Team Captain

December 9, 2014

0 Comments

Tommy Garceau, IMBCR’s Marathon Team Captain

Tommy, who has been Dr. Berenson’s able assistant for many years, has a passion for athletics and training. In July 2013, he started Team IMBCR at a time when he was also participating in several marathons, half-marathons and trail running and half iron distance events. Team IMBCR later became an official charity of the 2014 […]

Continue reading...

Multiple Myeloma: ‘Old Rules’ No Longer Apply

April 25, 2014

0 Comments

Original Article Writen by: Robert Carlson – Oncology Times NEW YORK—Treatment regimens for relapsed/refractory multiple myeloma have become plentiful in the past few years, with a panoply of options. Consequently, “the old rules no longer apply,” says James Berenson, MD, President and Chief Medical Officer of the Institute for Myeloma and Bone Cancer Research in West Hollywood, Calif., speaking […]

Continue reading...

KTLA Twitter Post

March 14, 2014

0 Comments

Continue reading...

IMBCR – KTLA 5 News – Segment 2

March 6, 2014

0 Comments

Continue reading...

IMBCR – KTLA 5 News – Segment 1

March 6, 2014

0 Comments

Continue reading...

IMBCR – KTLA 5 News – Segment 4

March 6, 2014

0 Comments

Continue reading...